Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Sunday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Price Performance

NYSE RVP opened at $0.90 on Friday. Retractable Technologies has a 1 year low of $0.87 and a 1 year high of $1.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. The company has a fifty day moving average of $1.05 and a 200 day moving average of $1.09.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. The company had revenue of $6.03 million during the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.